Research from Doulatov Lab in the Journal Blood Offers Stem Cell-Aided Insights on MDS Onset
June 13, 2019 | Categories: Research |Myelodysplastic syndromes (MDS) are heterogenous blood disorders that affect up to 170,000 people in the United States, primarily over the age of 60. While early symptoms, including anemia (characterized by fatigue), are not serious, MDS is a high-risk factor for leukemia. Currently there are few treatment for MDS and the causes remain poorly understood. Read More